A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis

PHASE2CompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

July 1, 2019

Conditions
Endometriosis
Interventions
DRUG

Placebo

Placebo tablets for oral administration once daily

DRUG

OBE2109

OBE2109 tablets for oral administration once daily

Trial Locations (86)

Unknown

Site reference ID 455, Chandler

Site reference ID 439, Scottsdale

Site reference ID 462, Arcadia

Site reference ID 405, Chino

Site reference ID 463, Huntington Park

Site refenrec ID 469, Northridge

Site reference ID 431, San Diego

Site reference ID 440, Tustin

Site reference ID 474, Denver

Site reference ID 450, Lakewood

Site reference ID 425, Longmont

Site reference ID 410, Washington D.C.

Site reference ID 457, Boca Raton

Site reference ID 418, Clearwater

Site reference ID 437, Gainesville

Site reference ID 458, Jensen Beach

Site reference ID 411, Miami

Site reference ID 424, Miami

Site reference ID 435, Miami

Site reference ID 420, Miami Lakes

Site reference ID 441, Miami Springs

Site reference ID 423, New Port Richey

Site reference ID 426, Tampa

Site reference ID 442, Wellington

Site reference ID 428, Atlanta

Site reference ID 459, Atlanta

Site reference ID 475, Nampa

Site reference ID 465, Oak Brook

Site reference ID 404, Shawnee Mission

Site reference ID 456, Wichita

Site reference ID 454, Marrero

Site reference ID 453, Metairie

Site reference ID 478, Glen Burnie

Site reference ID 445, Fall River

Site reference ID 471, Fall River

Site reference ID 430, Ann Arbor

Site reference ID 409, Bay City

Site reference ID 468, Saginaw

Site reference ID 473, Saginaw

Site reference ID 427, Southfield

Site reference ID 421, Albuquerque

Site reference ID 466, New York

Site reference ID 436, Greensboro

Site reference ID 433, Morehead City

Site reference ID 443, Dayton

Site reference ID 472, Franklin

Site reference ID 415, Tiffin

Site reference ID 414, Westerville

Site reference ID 419, Bryn Mawr

Site reference ID 449, Jenkintown

Site reference ID 476, Columbia

Site reference ID 408, Bristol

Site reference ID 403, Chattanooga

Site reference ID 429, Nashville

Site reference ID 452, Austin

Site reference ID 461, Beaumont

Site reference ID 447, Dallas

Site reference ID 460, Dallas

Site reference ID 464, Fort Worth

Site reference ID 413, Houston

Site reference ID 434, Houston

Site reference ID 479, Houston

Site reference ID 451, San Antonio

Site reference ID 402, Schertz

Site reference ID 432, Webster

Site reference ID 422, Draper

Site reference ID 467, Centreville

Site reference ID 407, Norfolk

Site reference ID 412, Richmond

Site reference ID 417, Richmond

Site reference ID 406, Seattle

Site reference ID 101, Katowice

Site reference ID 102, Katowice

Site reference ID 104, Lublin

Site reference ID 105, Lublin

Site reference ID 103, Szczecin

Site reference ID 201, Moscow

Site reference ID 202, Moscow

Site reference ID 203, Moscow

Site reference ID 204, Moscow

Site reference ID 205, Saint Petersburg

Site reference ID 305, Ivano-Frankivsk

Site reefrence ID 303, Kyiv

Site reference ID 301, Kyiv

Site reference ID 302, Kyiv

SIte reference ID 304, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ObsEva SA

INDUSTRY